Peripheral Alveolar Nitric Oxide Concentration Reflects Alveolar Inflammation in Autoimmune Pulmonary Alveolar Proteinosis

Overview

Journal ERJ Open Res

Specialty Pulmonary Medicine

Date 2018 Mar 27

PMID 29577041

Citations 2

Authors

Taizou Hirano

Shinya Ohkouchi

Naoki Tode

Makoto Kobayashi

Manabu Ono

Teruyuki Satoh

Yoichiro Mitsuishi

Akira Watanabe

Masao Tabata

Toshiya Irokawa

Hiromasa Ogawa

Hisatoshi Sugiura

Toshiaki Kikuchi

Keiichi Akasaka

Ryushi Tazawa

Yoshikazu Inoue

Koh Nakata

Hajime Kurosawa

Masakazu Ichinose

Affiliations

Soon will be listed here.

Abstract

http://ow.ly/czCx30i12n8.

Citing Articles

[Alveolar nitric oxide concentration has a potential value in the diagnosis and differential diagnosis of interstitial lung diseases].

Chang X, Chen M, Liao H, Dong H, Cai S Nan Fang Yi Ke Da Xue Xue Bao. 2023; 43(8):1410-1416.

PMID: 37712279 PMC: 10505563. DOI: 10.12122/j.issn.1673-4254.2023.08.19.

Influenza B: Prospects for the Development of Cross-Protective Vaccines.

Tsybalova L, Stepanova L, Ramsay E, Vasin A Viruses. 2022; 14(6).

PMID: 35746794 PMC: 9228933. DOI: 10.3390/v14061323.

References

Barnes P, Dweik R, Gelb A, Gibson P, George S, Grasemann H . Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest. 2010; 138(3):682-92. DOI: 10.1378/chest.09-2090. View

Tazawa R, Trapnell B, Inoue Y, Arai T, Takada T, Nasuhara Y . Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2010; 181(12):1345-54. PMC: 2894410. DOI: 10.1164/rccm.200906-0978OC. View

Hirano T, Matsunaga K, Sugiura H, Minakata Y, Koarai A, Akamatsu K . Relationship between alveolar nitric oxide concentration in exhaled air and small airway function in COPD. J Breath Res. 2013; 7(4):046002. DOI: 10.1088/1752-7155/7/4/046002. View

Inoue Y, Trapnell B, Tazawa R, Arai T, Takada T, Hizawa N . Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med. 2008; 177(7):752-62. PMC: 2720118. DOI: 10.1164/rccm.200708-1271OC. View

Abba A . Exhaled nitric oxide in diagnosis and management of respiratory diseases. Ann Thorac Med. 2009; 4(4):173-81. PMC: 2801041. DOI: 10.4103/1817-1737.56009. View

Tiev K, Hua-Huy T, Kettaneh A, Allanore Y, Le-Dong N, Duong-Quy S . Alveolar concentration of nitric oxide predicts pulmonary function deterioration in scleroderma. Thorax. 2011; 67(2):157-63. DOI: 10.1136/thoraxjnl-2011-200499. View

Horvath I, Barnes P, Loukides S, Sterk P, Hogman M, Olin A . A European Respiratory Society technical standard: exhaled biomarkers in lung disease. Eur Respir J. 2017; 49(4). DOI: 10.1183/13993003.00965-2016. View

Dweik R, Boggs P, Erzurum S, Irvin C, Leigh M, Lundberg J . An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011; 184(5):602-15. PMC: 4408724. DOI: 10.1164/rccm.9120-11ST. View

Ono M, Saito R, Tominaga J, Okada Y, Ohkouchi S, Takemura T . Pathological features of explant lungs with fibrosis in autoimmune pulmonary alveolar proteinosis. Respirol Case Rep. 2017; 5(5):e00255. PMC: 5520874. DOI: 10.1002/rcr2.255. View

10.

Murray P, Allen J, Biswas S, Fisher E, Gilroy D, Goerdt S . Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014; 41(1):14-20. PMC: 4123412. DOI: 10.1016/j.immuni.2014.06.008. View

11.

Wicks I, Roberts A . Targeting GM-CSF in inflammatory diseases. Nat Rev Rheumatol. 2015; 12(1):37-48. DOI: 10.1038/nrrheum.2015.161. View

12.

Hirano T, Kikuchi T, Tode N, Santoso A, Yamada M, Mitsuhashi Y . OX40 ligand newly expressed on bronchiolar progenitors mediates influenza infection and further exacerbates pneumonia. EMBO Mol Med. 2016; 8(4):422-36. PMC: 4818750. DOI: 10.15252/emmm.201506154. View

13.

Fleetwood A, Lawrence T, Hamilton J, Cook A . Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J Immunol. 2007; 178(8):5245-52. DOI: 10.4049/jimmunol.178.8.5245. View

14.

Murray P, Wynn T . Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011; 11(11):723-37. PMC: 3422549. DOI: 10.1038/nri3073. View

15.

Dalrymple H, Barna B, Malur A, Malur A, Kavuru M, Thomassen M . Alveolar macrophages of GM-CSF knockout mice exhibit mixed M1 and M2 phenotypes. BMC Immunol. 2013; 14:41. PMC: 3848434. DOI: 10.1186/1471-2172-14-41. View